T-cadherin is critical for adiponectin-mediated cardioprotection in mice.

The circulating, adipocyte-secreted hormone adiponectin (APN) exerts protective effects on the heart under stress conditions. The receptors binding APN to cardiac tissue, however, have remained elusive. Here, we report that the glycosyl phosphatidylinositol–anchored cell surface glycoprotein T-cadherin (encoded by Cdh13) protects against cardiac stress through its association with APN in mice. We observed extensive colocalization of T-cadherin and APN on cardiomyocytes in vivo. In T-cadherin-deficient mice, APN failed to associate with cardiac tissue, and its levels dramatically increased in the circulation. Pressure overload stress resulted in exacerbated cardiac hypertrophy in T-cadherin-null mice and paralleled corresponding defects in mice lacking APN. During ischemia-reperfusion injury, the absence of T-cadherin increased infarct size similar to that in APN-null mice. Myocardial AMPK is a major downstream protective signaling target of APN. In both cardiac hypertrophy and ischemia-reperfusion models, T-cadherin was necessary for APN-dependent AMPK phosphorylation. In APN-null mice, recombinant adenovirus-expressed APN reduced exaggerated hypertrophy and infarct size and restored AMPK phosphorylation as previously reported. In contrast, rescue was ineffective in mice lacking T-cadherin in addition to APN. These data suggest that T-cadherin protects from stress-induced pathological cardiac remodeling by binding APN and activating its cardioprotective functions.

[1]  H. Eppenberger,et al.  N-Cadherin: Structure, Function and Importance in the Formation of New Intercalated Disc-Like Cell Contacts in Cardiomyocytes , 2000, Heart Failure Reviews.

[2]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[4]  B. Fredette,et al.  T-cadherin expression delineates specific regions of the developing motor axon-hindlimb projection pathway , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling* , 2004, Journal of Biological Chemistry.

[6]  M. Bohlooly-y,et al.  Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.

[7]  B. Viollet,et al.  AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice , 2008, Hypertension.

[8]  岩嶋 義雄 Hypoadiponectinemia is an Independent Risk Factor for Hypertension , 2004 .

[9]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[10]  R. Cardiff,et al.  T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.

[11]  M. Eisenberg,et al.  Cardiac resuscitation. , 2001, The New England journal of medicine.

[12]  G. Morley,et al.  Cardiac-Specific Loss of N-Cadherin Leads to Alteration in Connexins With Conduction Slowing and Arrhythmogenesis , 2005, Circulation research.

[13]  L. Luttrell,et al.  The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. , 2008, Biochemistry.

[14]  Shyi-Jang Shin,et al.  Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[15]  T. Murohara,et al.  Adiponectin and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[16]  G. Goings,et al.  T-cadherin Is a Major Glycophosphoinositol-anchored Protein Associated with Noncaveolar Detergent-insoluble Domains of the Cardiac Sarcolemma* , 1998, The Journal of Biological Chemistry.

[17]  T. Murohara,et al.  Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. , 2010, Journal of molecular and cellular cardiology.

[18]  B. Ranscht,et al.  T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.

[19]  A. Utani,et al.  T‐cadherin enhances cell–matrix adhesiveness by regulating β1 integrin trafficking in cutaneous squamous carcinoma cells , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[20]  F. Meerson On the mechanism of compensatory hyperfunction and insufficiency of the heart. , 1961, Cor et vasa.

[21]  P. Erne,et al.  Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  C. Lavie,et al.  Clinical impact of left ventricular hypertrophy and implications for regression. , 2009, Progress in cardiovascular diseases.

[23]  M. Bronner‐Fraser,et al.  T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo. , 1991, Development.

[24]  B. Maron Sudden death in young athletes. , 1980, The New England journal of medicine.

[25]  Christian Gieger,et al.  Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations , 2009, Human molecular genetics.

[26]  S. Kihara,et al.  Adiponectin protects against the development of systolic dysfunction following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.

[27]  Renee Dickie,et al.  The FASEB Journal • Research Communication Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy , 2022 .

[28]  S. Kash,et al.  Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. , 2007, Endocrinology.

[29]  I. Komuro,et al.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.

[30]  J. Pollard,et al.  Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo , 2009, Clinical Cancer Research.

[31]  B. Fredette,et al.  Inhibition of motor axon growth by T-cadherin substrata. , 1996, Development.

[32]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[33]  B. Honig,et al.  T-cadherin structures reveal a novel adhesive binding mechanism , 2010, Nature Structural &Molecular Biology.

[34]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[35]  Jonathan C. Cohen,et al.  Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS Stud , 2009, Obesity.

[36]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[37]  C. Berne,et al.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. , 2007, The Journal of clinical endocrinology and metabolism.

[38]  W. Rogers,et al.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.

[39]  Y. Hayashi,et al.  Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.

[40]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[41]  H. Seo,et al.  Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index , 2004, Blood pressure.

[42]  J. Schmitt,et al.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. , 2002, The Journal of clinical investigation.

[43]  B. Gersh,et al.  Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.

[44]  B. Ranscht,et al.  Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium- dependent, homophilic cell adhesion , 1992, The Journal of cell biology.

[45]  T. Beaty,et al.  Adiponectin concentrations: a genome-wide association study. , 2010, American journal of human genetics.

[46]  R. Cardiff,et al.  Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer , 2009, Clinical Cancer Research.

[47]  C. Lewis,et al.  QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study , 2008, BMC Medical Genetics.

[48]  NoriyukiOuchi,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003 .

[49]  藤岡 大佑 Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart , 2007 .

[50]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[51]  M. Eisenberg,et al.  Primary care : Cardiac resuscitation , 2001 .

[52]  Meerson Fz On the mechanism of compensatory hyperfunction and insufficiency of the heart. , 1961 .

[53]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[54]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[55]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[56]  P. Erne,et al.  Integrin‐linked kinase is an essential mediator for T‐cadherin‐dependent signaling via Akt and GSK3β in endothelial cells , 2007 .